DoctorsProofNPPES directory · verify at state boards

Cardiovascular Disease in Albuquerque, NM

65 verified cardiovascular disease doctors in Albuquerque. Page 2 of 2.

Cardiologists diagnose and treat conditions of the heart and blood vessels, including heart disease, arrhythmias, and heart failure.

NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.

Verify a license at the New Mexico Medical Board

Dr. Edwin Grajeda Silvestri, MD

Cardiovascular Disease

10 yrs NPPES
NPI 1427408525
201 CEDAR ST SE STE 7600, Albuquerque, NM 87106(505) 563-2500
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $533.50 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$533.50

Total received

13

Transactions

2

Paying companies

Top paying companies

Abbott Laboratories$508.36
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)$25.14

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 64th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Edwin Grajeda Silvestri do not imply any wrongdoing. Many are meals, education, or research support.

Dr. Jacob Mayfield, MD

Cardiovascular Disease

9 yrs NPPES
NPI 1235660689
201 CEDAR ST SE STE 4610, Albuquerque, NM 87106(505) 563-2500
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Mary Ann Lukas, MD

Cardiovascular Disease

9 yrs NPPES
NPI 1104338672
9328 DEL ARROYO AVE NE, Albuquerque, NM 87122(505) 797-1394
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Alyce Dechant, MD

Cardiovascular Disease

9 yrs NPPES
NPI 1366954190
1101 -4 MEDICAL ARTS AVE NE, Albuquerque, NM 87131(505) 272-2273
NPPES public registry
CMS Open Payments· No payments in 2023

Industry Payments

No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.

Dr. Mark Belill, MD

Cardiovascular Disease

7 yrs NPPES
NPI 1528604956
1101 MEDICAL ARTS AVE NE, Albuquerque, NM 87102(505) 272-2273
NPPES public registryAccepts Medicare (2024)
CMS Open Payments· $653.86 (2023)

Industry Payments (2023)

Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.

$653.86

Total received

20

Transactions

8

Paying companies

Top paying companies

AstraZeneca Pharmaceuticals LP$294.76
Pfizer Inc.$96.48
Boehringer Ingelheim Pharmaceuticals, Inc.$94.05
NOVARTIS PHARMACEUTICALS CORPORATION$78.15
Actelion Pharmaceuticals US, Inc.$36.27
Merck Sharp & Dohme LLC$25.82

Among the 26,323 cardiovascular disease doctors we've analyzed, about 66% received any industry payment (median $653 among those who did). This doctor's total ranks around the 67th percentile of that group.

Benchmark reflects doctors we've analyzed, not all US cardiovascular disease doctors.

Payments to Mark Belill do not imply any wrongdoing. Many are meals, education, or research support.

Cardiovascular Disease in Albuquerque, NM — Verified | DoctorsProof — Page 2 | DoctorsProof